Hexapeptide derivatives of glycopeptide antibiotics: Tools for mechanism of action studies

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 8, 2002, Pages 2344-2348

  Allen, Norris E ^a   LeTourneau, Deborah L ^a   Hobbs Jr , Joe N ^a   Thompson, Richard C ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 EPI VANCOSAMINE; ANTIBIOTIC AGENT; CHLOROORIENTICIN A; GLYCOPEPTIDE ANTIBIOTIC; HEXAPEPTIDE; LY 307599; LY 312607; LY 314015; N,N' DIACETYLLYSYL DEXTRO ALANYL DEXTRO ALANINE; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; DRUG DERIVATIVE; LIGAND; MEMBRANE PROTEIN;

ALKYLATION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BINDING AFFINITY; CONTROLLED STUDY; DIMERIZATION; DRUG MECHANISM; ELECTROPHORETIC MOBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; LIGAND BINDING; MEMBRANE VESICLE; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; ALGORITHM; CELL MEMBRANE; CELL WALL; CHEMISTRY; DRUG EFFECT; MEMBRANE; METABOLISM; MICROBIOLOGICAL EXAMINATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; SYNTHESIS;

ALGORITHMS; ALKYLATION; ANTIBIOTICS, GLYCOPEPTIDE; BACTERIAL PROTEINS; CELL MEMBRANE; CELL WALL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; LIGANDS; MEMBRANE PROTEINS; MEMBRANES; MICROBIAL SENSITIVITY TESTS; MICROCOCCUS LUTEUS; PROTEIN BINDING; VANCOMYCIN; ANTI-BACTERIAL AGENTS;

EID: 0035991714     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.8.2344-2348.2002     Document Type: Article

References (38)

1. Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semi-synthetic glycopeptide antibiotic
2. Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues
3. The role of hydrophobic side chains as determinants of antibacterial activity of semisynthetic glycopeptide antibiotics
4. The structure and mode of action of glycopeptide antibiotics of the vancomycin group
5. Semiquantitation of cooperativity in binding of vancomycin-group antibiotics to vancomycin-susceptible and -resistant organisms
6. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics
7. The Edman degradation of vancomycin: Preparation of vancomycin hexapeptide
8. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: Biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA
9. Affinity capillary electrophoresis can simultaneously measure binding constants of multiple peptides to vancomycin
10. Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers
11. Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacterium
12. Reductive alkylation of glycopeptide antibiotics: Synthesis and antibacterial activity
13. 19F NMR in the measurement of binding affinities of chloroeremomycin to model bacterial cell-wall surfaces that mimic VanA and VanB resistance
14. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala
15. The role of the sugar and chlorine substituents in the dimerization of vancomycin antibiotics
16. Chlorobiphenyl-desleucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide binding
17. Determination of binding constants of ligands to proteins by affinity capillary electrophoresis: Compensation for electroosmotic flow
18. The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics
19. The role of hydrophobic substituents in the biological activity of glycopeptide antibiotics
20. New procedure for the isolation of membrane vesicles of Bacillus subtilis and an electron microscopy study of their ultrastructure
21. Use of capillary electrophoresis to measure dimerization of glycopeptide antibiotics
22. Dissection of the contributions towards dimerization of glycopeptide antibiotics
23. Glycopeptide antibiotic activity and the possible role of dimerization: A model for biological signalling
24. Structure-activity relationships of vancomycin antibiotics
25. Structure-activity relationships of vancomycin-type glycopeptide antibiotics
26. Resistance and mode of action
27. Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria
28. Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci
29. Chemistry, biology, and medicine of the glycopeptide antibiotics
30. High affinity surface binding of a strongly dimerizing vancomycin-group antibiotic to a model of resistant bacteria
31. The chemical basis for the action of the vancomycin group of antibiotics
32. A fluorescent ligand for binding studies with glycopeptide antibiotics of the vancomycin class
33. Structure, biochemistry and mechanism of action of glycopeptide antibiotics
34. Novel glycopeptide antibiotics: N-alkylated derivatives active against vancomycin-resistant enterococci
35. In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer
36. Effect of LY333328 against vancomycin-resistant Enterococcus faecium in a rat central venous catheter-associated infection model
37. The roles of dimerization and membrane anchoring in activity of glycopeptide antibiotics against vancomycin-resistant bacteria
38. Bacterial resistance to vancomycin: Five genes and one missing hydrogen bond tell the story